The P2Y1 receptor is essential for ADP-induced shape change and aggregation in mouse platelets

Platelets

Volumn 10, Issue 6, 1999, Pages 399-406

  Kim, Young B ^a   Jin, Jianguo ^a   Dangelmaier, Carol ^a   Daniel, James L ^a   Kunapuli, Satya P ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENYLATE CYCLASE; ANTISERUM; PURINE P2Y RECEPTOR;

ANIMAL CELL; ARTICLE; CALCIUM MOBILIZATION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INHIBITION; HEMOSTASIS; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE SHAPE;

ANIMALIA; MUS MUSCULUS;

EID: 0033403707     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/09537109975870     Document Type: Article

References (33)

1. 1. Hellem A. The adhesivenes of human blood platelets in vitro. Scand J Clin Invest 1960; 12: 1-17.
2. 2. Gaarder A, Jonsen A, Laland S, Hellem A J, Owren P. Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets. Nature 1961; 192: 531-2.
3. 3. Boeynaems J M, Pearson J D. P2 purinoceptors on vascular endothelial cells: Physiological significance and transduction mechanisms. Trends Pharmacol Sci 1990; 11: 34-7.
4. 4. Maffrand J P, Bernat A, Delebassee D, Defreyn G, Cazenave J P, Gordon J L. ADP plays a key role in thrombogenesis in rats. Thromb Haemost 1988; 59: 225-30.
5. 5. Daniel J L, Dangelmaier C, Jin J, Ashby B, Smith B, Kunapuli S P. Molecular basis for ADP-induced platelet activation I: Evidence for three distinct ADP receptors on platelets. J Biol Chem 1998; 273: 2024-9.
6. 6. Jin J, Daniel J L, Kunapuli S P. Molecular basis for ADP-induced platelet activation II: The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets. J Biol Chem 1998; 273: 2030-4.
7. 2Τpurinoceptors. Br J Pharmacol 1994; 113: 1057-63.
8. 1 receptor. Mol Pharmacol 1996; 50: 1323-9.
9. 9. MacKenzie A B, Mahaut-Smith M P, Sage S O. Activation of receptor-operated cation channels via P2X1 not P2T purinoceptors in human platelets. J Biol Chem 1996; 271: 2879-81.
10. 10. Leon C, Hechler B, Vial C, Leray C, Cazanave J P, Gachet C. The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells. FEBS Lett 1997; 403 (1): 26-30.
11. 11. Schachter J B, Li Q, Boyer J L, Nicholas R A, Harden T K. Second messenger cascade specificity and pharmacological selectivity of the human P2Y1-purinoceptor. Br J Pharmacol 1996; 118 (1): 167-73.
12. 12. Offermanns S, Toombs C F, Hu Y, Simon M I. Defective platelet activation in Gαq-deficient mice. Nature 1997; 389: 183-6.
13. 12 proteins. Biochem J 1995; 312: 775-9.
14. 14. Geiger J, Honig-Liedl P, Schanzenbacher P, Walter U. Ligand specificity and ticlopidine effects distinguish three human platelet ADP receptors. Eur J Pharmacol 1998; 351: 235-46.
15. 15. Fagura M S, Dainty I A, McKay G D, Kirk R G, Humphries R G, Robertson M J, Dougall I G, Leff P. P2Y1-receptors in human platelets which are pharmacologically distinct from P2YADP-receptors. Br J Pharmacol 1998; 124: 157-64.
16. 1 receptor is necessary for adenosine 5′-diphosphate-induced platelet aggregation. Blood 1998; 92: 152-9.
17. 17. Jantzen H-M, Gousset L, Bhaskar V, Vincent D, Tai A, Reynolds E, Conley P D. Evidence for two distinct G protein-coupled ADP receptors mediating platelet activation. Thromb Haemost 1999; 81: 111-7.
18. 18. Jin J, Kunapuli S P. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proc Natl Acad Sci USA 1998; 95: 8070-4.
19. 19. Savi P, Beauverger P, Labouret C, Delfaud M, Salel V, Kaghad M, Herbert J M. Role of P2Y1 purinoceptor in ADP-induced platelet activation. FEBS Lett 1998; 422: 291-5.
20. 20. Connolly A J, Ishihara H, Kahn M L, Farese Jr R V, Coughlin S R. Role of the thrombin receptor in development and evidence for a second receptor. Nature 1996; 381: 516-9.
21. 3H]-platelet activating factor (PAF) to the platelet. Biochem Pharmacol 1985; 34 (9): 1491-5.
22. 22. DiMonno G, Silver M J. Mouse antithrombotic assay: A simple method for the evaluation of antithrombotic agents in vivo. Potentiation of antithrombotic activity by ethyl alcohol. J Pharmacol Exp Ther 1983; 255: 57-60.
23. 23. Rosenblum W I, Nelson G H, Cockrell C S, Ellis E F. Some properties of mouse platelets. Thromb Res 1983; 30: 347-55.
24. 24. Duarte A P T, Ramwell P, Myers A. Sex differences in mouse platelet aggregation. Thromb Res 1986; 43: 33-9.
25. 25. Ayyanathan K, Webbs T E, Sandhu A K, Athwal R S, Barnard E A, Kunapuli S P. Cloning and chromosomal localization of human P2Y1 purinoceptor. Biochem Biophys Res Commun 1996; 218: 783-8.
26. 26. Leon C, Vial C, Cazenave J P, Gachet C. Cloning and sequencing of a human cDNA encoding endothelial P2Y1 purinoceptor. Gene 1996; 171: 295-7.
27. 27. Salomon Y. Adenylate cyclase assay. Adv Cyclic Nucleotide Res 1979; 10: 35-55.
28. 2Y purinoceptors. Biochem Biophys Res Commun 1995; 211: 211-8.
29. 29. Anderson G P, Anderson C L. Signal transduction by the platelet Fc receptor. Blood 1990; 76 (6): 1165-72.
30. 30. Mason R G, Read M S. Platelet response to six agglutinating agents: Species similarities and differences. Exp Mol Pathol 1967; 6: 370-81.
31. 31. DeClerck F, Xhonneux B, Leysen J, Jansscn PAJ. The involvement of 5-HT2-receptor sites in the activation of cat platelets. Thromb Res 1984; 33: 305-21.
32. 32. Leon C, Hechler B, Vial C, Freund M, Ohlmann P, Dierich A, LeMeur M, Cazenave J-P, Gachet C. Platelets from P2Y1 receptor knockout mice do not aggregate in response to ADP. Thromb. Haemost 1999; 82 (Suppl): 1331 (abstract).
33. 33. Fabre JE, Nguyen M, Latour A, Keifer JA, Audoly LP, Coffman TM, Koller BH. Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nat Med 1999; 5: 1199-202.